CompanyStageLast valuationTotal raised
EEvotec (UK) LimitedUK private limited company incorporated 1991.Late stageHealthcareLast valuationUndisclosedTotal raised$0EExactics, Inc.Private securities offering disclosed via SEC Form D.SeedHealthcareLast valuationUndisclosedTotal raised$855KEEyebiotech LimitedUK private limited company incorporated 2021.Late stageHealthcareLast valuationUndisclosedTotal raisedSign inFFederated Biologics Inc.Private securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$6MFFerring Ventures LTDUK private limited company incorporated 1997.Late stageHealthcareLast valuationUndisclosedTotal raised$0FFios Genomics LimitedUK private limited company incorporated 2008.Late stageHealthcareLast valuationUndisclosedTotal raisedSign inFFlatiron Health UK LTDUK private limited company incorporated 2019.Late stageHealthcareLast valuationUndisclosedTotal raised$0F
FluidForm Bio, Inc.Raised capital from retail investors through a Regulation Crowdfunding offering on StartEngine Primary, LLC.SeedHealthcareLast valuationUndisclosedTotal raised$1.7MFFORE US Bio Inc.Private securities offering disclosed via SEC Form D.Series CHealthcareLast valuationUndisclosedTotal raised$70.4MFF-Star Therapeutics LimitedUK private limited company incorporated 2018.Late stageHealthcareLast valuationUndisclosedTotal raised$0FFuturagene LimitedUK private limited company incorporated 2000.Late stageHealthcareLast valuationUndisclosedTotal raised$0FFutura Medical Developments LimitedUK private limited company incorporated 1997.Late stageHealthcareLast valuationUndisclosedTotal raised$0GGaius Therapeutics, Inc,Private securities offering disclosed via SEC Form D.SeedHealthcareLast valuationUndisclosedTotal raised$60KG
Galaxy Diagnostics, Inc.Won 2 federal SBIR/STTR research awards from HHS and other federal agencies.SeedHealthcareLast valuationUndisclosedTotal raised$3MGGammadelta Therapeutics LTDUK private limited company incorporated 2016.Late stageHealthcareLast valuationUndisclosedTotal raisedSign inGGelMEDIX, Inc.GelMEDIX, Inc., based in Cambridge, Massachusetts, develops ocular cell therapies aimed at restoring vision.SeedHealthcareLast valuationUndisclosedTotal raisedSign inGGenesis New Ventures, LLCPrivate securities offering disclosed via SEC Form D.SeedHealthcareLast valuationUndisclosedTotal raised$4.2MGGenincode PLCUK public limited company incorporated 2018.PublicHealthcareLast valuationUndisclosedTotal raised$0GGenomics England LimitedUK private limited company incorporated 2013.Late stageHealthcareLast valuationUndisclosedTotal raised$0GGenomics LimitedUK private limited company incorporated 2014.Late stageHealthcareLast valuationUndisclosedTotal raisedSign inGGenscript Biotech (UK) LimitedUK private limited company incorporated 2021.Late stageHealthcareLast valuationUndisclosedTotal raised$0GGoldenrod Therapeutics, Inc.Goldenrod Therapeutics, Inc., founded in 2020 in Houston, develops PDE4 inhibitors for severe neurological disorders.SeedHealthcareLast valuationUndisclosedTotal raised$3.2MGGossamer Bio, Inc.Gossamer Bio, Inc. is a San Diego biopharmaceutical company developing seralutinib for pulmonary arterial hypertension and PH-ILD.Series BHealthcareLast valuationUndisclosedTotal raisedSign inGGowan Crop Protection LimitedUK private limited company incorporated 2015.Late stageSupport activities for crop productionLast valuationUndisclosedTotal raised$0GGraviton BioScience CorpPrivate securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$5M